Clinical Trial Update: A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy [Phase 2]

View source ↗

Summary

A Phase 2 multicenter, double-blind, placebo-controlled study evaluating atrasentan, including thoracic bioimpedance, in adults with type 2 diabetes and nephrop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetic Nephropathy

Drugs mentioned

• Atrasentan (atrasentan)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Chronic Kidney Disease, Diabetic Nephropathy | Phase 2 | Status: COMPLETED